The largest database of trusted experimental protocols

5 protocols using ab2904

1

Quantifying Angiogenic and Apoptotic Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total protein of the tumour tissues was extracted using radioimmunoprecipitation assay lysis buffer (Beyotime, Shanghai, China) containing proteinase inhibitor cocktail, and the concentration of protein was determined using a bicinchoninic acid assay. Proteins (50 µg) were separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis and then transferred onto polyvinylidene fluoride membranes (EMD Millipore, USA). The membranes were blocked with 5% skimmed milk at 4 °C overnight and incubated with primary antibodies against VEGFR2 (1:1,000; ab11939, Abcam), angiostatin (1:2,000; ab2904, Abcam), endostatin (1:500; ab202973, Abcam), Bcl-2 (1:1,000; ab32124, Abcam), and Bax (1:2,000; ab32503, Abcam) at 4 °C overnight. After incubating with sheep anti-rabbit IgG (1:5,000; ab97095; Abcam) at 37 °C for 1 h, protein bands were visualised using the enhanced chemiluminescence system (Thermo Fisher Scientific, Inc.). Protein expression levels were normalised to GAPDH expression (1:10,000; ab181602; Abcam) and quantified using ImageJ software version 1.46 (NIH).
+ Open protocol
+ Expand
2

Western Blot Analysis of Angiostatin and VEGF

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total protein extracts (20 µg) were separated on TGX 4%–20% precast gradient gels (Bio-Rad, Germany) and transferred onto nitrocellulose membranes. The membranes were blocked in 5% milk (for anti-angiostatin antibody) or 3% milk (for anti-VEGFα and anti-α-actinin antibodies). The membranes were then incubated with the following primary antibodies:
Polyclonal rabbit-a-angiostatin (Abcam, ab2904) 2 µg/ml in 5% milk, overnight at 4°C; monoclonal mouse-a-VEGFα (Abcam, ab1316), 5 µg/ml in tris-buffered saline (TBS)/T, 1 h at room temperature; rabbit-a-α-actinin (Cell Signaling, 3134), 1:1,000 in 5% milk, overnight at 4°C. After washing with TBS/T, the membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (sheep anti-mouse, Jackson ImmunoResearch 515-035-003, 1:20,000 in 3% milk; goat anti-rabbit, Jackson ImmunoResearch JIM-111-035-003, 1:10,000 in 5% milk), washed again, and specific signals were detected using the ECL or Femto system (Thermo Fisher) according to the manufacturer's protocol. A densitometric analysis of the protein bands was done using ImageLab (Bio-Rad).
+ Open protocol
+ Expand
3

Immunofluorescence Imaging of Aortic Angiostatin and VEGF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin sections (3 µm) of aortic vessels from WT and α-GAL-Tg/KO mice were deparaffinized and incubated in a 10 mM citrate buffer at 95°C for 40 min for antigen retrieval. Afterward, the sections were incubated for 10 min in 0.5% Triton/TBS for permeabilization, washed in TBS, and quenched in a 0.25% Sudan black solution for 30 min on a shaker in the dark. After repeated washing, the sections were blocked in 3% bovine serum albumin (BSA) in TBS for 1 h at room temperature. The sections were then incubated with primary antibodies [anti-angiostatin (Abcam ab2904), 1:20 in 3% BSA or anti-VEGFα (Abcam, ab1316), 1:400 in 3% BSA] overnight at 4°C, washed in TBS, and incubated with secondary antibodies [donkey anti-mouse Alexa Fluor 488 (A21202 life tech) or donkey anti-rabbit Alexa Fluor 488 (21206 life tech), 1:500 in 3% BSA] for 2 h at room temperature. After repeated washing in TBS, the slides were mounted with DAPI Fluoromount G (Biozol) and fluorescence signals were descriptively analyzed using a Zeiss Axiovert M200 with ApoTome.
+ Open protocol
+ Expand
4

Angiostatin Analysis in Tumor-Bearing Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Equal amounts of plasma proteins were analyzed by gelatin zymography, as previously described. 71 Plasma from tumorbearing mice was obtained by collection of blood using heparin microvettes (20.1282.100; Sarstedt, Nümbrecht, Germany), followed by centrifugation for 20 minutes at 1000 Â g. Plasma was precleared with protein G sepharose (17-0618-01; Amersham, GE Health Care), and unbound proteins were collected after centrifugation (1000 Â g for 10 minutes). Protein concentration was determined using the BCA assay, as described above. Total plasma proteins (20 mg) were resolved by SDS-PAGE on 12% polyacrylamide gels under reducing conditions and blotted, as described above. After blockage of non-specific binding sites with 5% skimmed milk (w/v) in PBS containing 0.5% Tween (v/v), the blots were incubated with the primary antibody against angiostatin (ab2904, 1:500; Abcam). Angiostatin bands (42-and 38-kDa fragments) were quantified by densitometry.
+ Open protocol
+ Expand
5

Quantifying Angiostatin and Endostatin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Angiostatin and endostatin proteins were visualised by IHC staining in the colon at 3, 6, and 15 week time points. A Dako automated staining system (Autostainer link 48 and PT Link, Dako, Denmark) was A c c e p t e d M a n u s c r i p t used with the EnVision™ FLEX kit for Dako autostainer link systems (Dako, Denmark) as previously described (Stansborough et al. 2017 ). The anti-angiostatin primary antibody (#ab2904, Abcam), and anti-endostatin primary antibody (#GTX37706, GeneTex), were used at 6.66 µl/ml and 20 µl/ml, respectively. Slides were scanned using the Nanozoomer (Hamamatsu Photonics, Japan) at 40x magnification. ImageScope imaging software (Leica Biosystems, Germany) was used to analyse angiostatin and endostatin in which percentage of positively stained cells was calculated in the lamina propria of each section (averaged from ten randomly selected 40x sections per slide).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!